SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Indevus Pharmaceuticals, Inc. Receives Approvable Letter from FDA for NEBIDO(R); Company Announces Revised Operating Plan to Respond to NEBIDO Delay